<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T06:22:15Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/24806" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/24806</identifier><datestamp>2026-09-24T01:06:25Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Melacini, Giuseppe</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Shao, Hongzhao</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Chemistry and Chemical Biology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2019-09-12T19:53:40Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2019-09-12T19:53:40Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2019</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/24806</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/11399</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">A novel partial agonist of the exchange protein activated by cAMP isoform 1&#xd;
(EPAC1), I942, was recently discovered and shown to reduce the guanine exchange&#xd;
factor activity of cAMP-bound EPAC1 to approximately 10% relative to cAMP&#xd;
activation. However, the inhibition mechanism of I942 remains unknown. Here, we&#xd;
utilize NMR spectroscopy to probe the inhibitory I942 - EPAC1 interactions at atomic&#xd;
resolution. The EPAC1 - I942 interface was mapped through intermolecular NOEs&#xd;
measured by 15N and 13C filtered NOESY-HSQC experiment. Intermolecular NOE&#xd;
mapping combined with other protein NMR methods, such as saturation transfer&#xd;
difference, transfer Nuclear Overhauser Effect spectroscopy and chemical shift mapping,&#xd;
we revealed that I942 interacts with the phosphate binding cassette (PBC) and base&#xd;
binding region (BBR) of the EPAC1 cyclic nucleotide binding (CNB) domain, similar to&#xd;
cAMP. The PBC controls the conformation of the hinge region, and subsequently,&#xd;
allosterically shifts the hinge region between its active/inactive states. Molecular&#xd;
dynamics simulation based on the NMR spectroscopy data revealed that EPAC1-CNB&#xd;
adopts an intermediate conformation between its inactive and active states, which&#xd;
explains the partial agonist nature of I942.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">The exchange protein activated by cAMP (EPAC) is a receptor for the classical&#xd;
secondary messenger cAMP. EPAC is present in multiple human systems and plays a&#xd;
pivotal role in the development of a wide range of diseases. In this study, we aim to&#xd;
establish the inhibition mechanism of a novel small molecule EPAC inhibitor/partial&#xd;
agonist I942 using NMR spectroscopy with the goal of achieving a better understanding&#xd;
of EPAC inhibition and paving the way for new small molecule EPAC inhibitors that can&#xd;
potentially treat EPAC-related diseases such as heart failure and diabetes.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">EPAC</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">competitive inhibitor</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">inhibition mechanism</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">NMR Spectroscopy</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Examining the Inhibition Mechanism of EPAC</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative" lang="en_US">Inhibition Mechanism of EPAC</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>